Invesco Ltd.

Position in IFRX — InflaRx N.V.

CIK 914208 Atlanta, GA

Position in IFRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$98,226

-$423,774 QoQ

Shares Held

43,851

-86.3% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#39

of 62 holders

Holding Since

Dec 2021

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. IFRX ranks #276 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,043,052	$3,995,225,212
2	REGN	Regeneron Pharmaceuticals, Inc.	3,940,665	$2,457,162,245
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,754,318	$1,130,162,341
4	INCY	Incyte Corp	4,080,461	$462,561,050
5	ARGX	Argenx SE	443,990	$411,920,598
6	AXSM	Axsome Therapeutics, Inc.	1,671,684	$409,178,086
7	MRNA	Moderna, Inc.	5,780,299	$404,794,337
8	LGND	Ligand Pharmaceuticals Inc	1,201,644	$379,827,645

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$98,226	43,851	-86.3%	Shares	Defined	2026-08-14
2023-12-31	$522,000	320,246	+95.3%	Shares	Defined	2024-02-13
2023-09-30	$488,571	163,950	+4.7%	Shares	Defined	2023-11-13
2023-06-30	$698,467	156,607	+144.7%	Shares	Defined	2023-08-11
2023-03-31	$124,150	63,995	+17.4%	Shares	Defined	2023-05-12
2022-12-31	$168,977	54,509	-79.8%	Shares	Defined	2023-02-13
2022-09-30	$712,470	269,875	+145.4%	Shares	Defined	2022-11-14
2022-06-30	$159,482	109,988	-51.5%	Shares	Defined	2022-08-15
2022-03-31	$414,696	226,610	+42.2%	Shares	Defined	2022-05-16
2021-12-31	$758,724	159,396	—	Shares	Defined	2022-02-14
No filing history on record for this holder in this stock.